ABSTRACT The following study was conducted to define how multiple nutritional strategies affect broiler performance, meat yield, and the presence and severity of white striping (WS) and woody breast (WB) in high-yielding broilers. Relative to a commercial set of reference broiler diets (Commercial reference diet; Trt 1) that were fed in a 4-phase program, the following nutritional strategies were investigated: increasing the ratio of digestible arginine: digestible lysine (dArg: dLys ranged from 113 to 126; Trt 2), supplementing Trt 1 with 94.4 mg vitamin C/kg feed (Trt 3), doubling the vitamin pack inclusion rate (Trt 4), reducing the digestible amino acid density (dAA) of only the grower phase by 15% and feeding the same Trt 1 starter, finisher, and withdraw diets (Trt 5), and combining the 4 strategies just mentioned (Trt 6). There was no difference in performance at the end of the starter phase (P = 0.066); however, at the end of the grower and finisher phases, feeding lower dAA grower diets suppressed BW (Trts 5 and 6; P < 0.001) and increased FCR. Differences in performance amongst all treatments disappeared at day 49 (P = 0.220). No differences were observed in average breast weight (P = 0.188); however, breast yield (as a % of live weight) was greatest for Trt 1 and least for Trt 6 (P = 0.041). The WB score dropped from 1.83 in Trt 1 to 1.49, 1.27, 1.74, 1.53, and 1.43 in treatments 2 to 6, respectively (P = 0.018). These changes were the result of a shift in WB score, where the WB class that contained scores of 2 and 3 shifted from 61.3% in Trt 1 to 49.3, 35.9, 60.0, 50.8, and 38.7 in treatments 2 to 6, respectively. Given the FCR, breast weight data and the fact that high WB scores result in a devaluation of breast meat, feeding a higher ratio of dArg: dLys, higher vitamin C, or lower dAA in the grower phase results in better breast meat quality and value.
INTRODUCTION
Over the past 70 yr, the broiler industry has intensely selected a number of meat-type chicken strains, with the result that today's broiler genetics have tremendous growth, feed efficiency, and meat yield potential. In a retrospective evaluation of broiler genetics from 1957 to 2005, Havenstein et al. (2003a,b) and Zuidhof et al. (2014) determined that both genetic selection and nutrition have had a significant effect upon the production efficiency and meat yield of the modern broiler, where the broiler's growth rate has increased over 300%, body weight (BW) has increased approximately 3.30% year over year, and feed conversion has dropped approx. 2.55% year over year. In fact, these authors suggest that approximately 85 to 90% of improvements are reportedly due to genetic selection for higher growth rate and C 2018 Poultry Science Association Inc. Received January 26, 2018. Accepted April 5, 2018. 1 Corresponding author: jtlee@tamu.edu feed intake. Based on an average straight-run growout for small to large bird programs, today's broilers are marketed at approximately 48.8 days of age, weigh approximately 2.98 kg/bird, have an average daily gain (ADG) of approximately 61.1 g/d, a breast meat yield range of approximately 24 to 26%, have a livability of approximately 95.4%, and are raised at a stocking density of approximately 827 cm 2 /bird (National Chicken Council, 2016) . Even though these statistics are derived from the top 25% of broiler complexes within the USA, the genetic potential of the commercial broiler is much greater. Modeling this potential in a 4-phase growout program, feeding high-yielding, male broilers a digestible amino acid (dAA) density that was 110% over that of commercial dLys levels from 0 to 42 d of age resulted in a BW of 3.77 kg/bird, an ADG of 89.8 g/d, a 1.60 feed conversion ratio (FCR), and a >95% incidence of severe muscle myopathies at processing (unpublished data from this lab). It is extremely important to note that these data were generated under special circumstances, and in no way, reflect current 3298 nutritional practices in the US commercial broiler industry. Regardless, these and other data in the literature indicate that although the broiler has the genetic potential for optimal performance, the propensity for a higher incidence of muscle myopathies can go up when a higher plane of nutrition is fed (i.e., dAA).
Together, genetic selection (i.e., for growth, feed conversion, and higher white meat yield), management, and nutrition have all had a positive influence on the final processing weight of broilers. Consequently, these have also increased the degree of myodegeneration, fibrosis, lipidosis, and regenerative changes within Pectoralis major filets (Petracci and Cavani, 2012; Kuttappan et al., 2016; Bowker and Zhuang, 2017) . These changes have resulted in producers, customers, and consumers observing an alteration in the quality of breast muscle tissue from the perspective of appearance, touch, and chewy texture (Gee, 2016) . Today, the 2 muscle quality issues that have garnered a majority of attention are white striping (WS) and woody breast (WB).
White striping in broilers is characterized by white striations that run parallel to the muscle fibers; these can be visualized on the surface of breast, thigh, and tenderloin (Kuttappan et al., 2013; Petracci et al., 2014) . This myopathy is not something that has recently appeared in broilers. Between 2012 and 2015, the incidence of severe WS dramatically increased from 5 to 29% of the broiler flocks/breast meat (Kuttappan et al., 2012b; Petracci et al., 2013; Owens and Alvarado, 2015; Russo et al., 2015; Bowker and Zhuang, 2017; Tijare et al., 2016) . Looking at the components of the P. major filet, Kuttappan et al. (2012b) ; Kuttappan et al. (2013) , and Petracci et al. (2014) reported that WS results in higher fat content and a lower, altered protein content and profile. In addition to a macro and microscopic alteration in the muscle's appearance (Kuttappan et al., 2009; Ferreira et al., 2014; Petracci et al., 2014; Bowker and Zhuang, 2017) , changes in protein content and functionality translate into significantly higher cook losses and reduced marinade uptake (Petracci et al., 2013; Petracci et al., 2014; Tijare et al., 2016 ). This is a major concern for divisions within a processing plant that "further processes" meat into other high-value products (Petracci et al., 2013; Mudalal et al., 2014; Tijare et al., 2016) . Aside from the scientific aspect of how changes in protein functionality affects further processing, surveys indicate that approximately half of all consumers (i.e., the general public that shops at grocery stores) would be less likely to purchase breast filets that contain WS (i.e., are striated or have a "fattier" appearance; Kuttappan et al. 2012a) .
Like WS, WB is reportedly linked to fast growth rate and an increase in breast meat yield (Sihvo et al., 2014>) ; it is found in varying degrees of severity and is characterized by changes in texture, fibrosis of the breast muscle, pale color, and a gelatinous exudate on the surface of the breast tissue (Tijare et al., 2016) . Woody breast severity can be evaluated on a scoring system established by Tijare et al. (2016) . The scores are assigned by the degree of hardness upon palpation of the breast fillet. A score of 0 represents a "normal" non-affected breast fillet. A score of 1 represents a mild hardness located within the cranial region. A score of 2 represents hardness that extends from the cranial region into the caudal region with limited or no flexibility. Lastly, a score of 3 represents the highest degree of severity, with hardness extending from the cranial region into the caudal region, with no flexibility and an outer bulge or ridge. Bowker and Zhuang (2017) recently reported on the compounded incidence of WB incidence across different WS scores; essentially, the higher the severity of WS, the higher the incidence of WB. The affected fillets have a reduced marinade uptake and higher cook loss due to fibrosis and an alteration in the sarcoplasmic, myofibrillar, and stromal proteins that are expressed in the breast meat (Mudalal et al., 2014; Sihvo et al., 2014; Barbut, 2015) . Like WS, the presence of WB in a breast filet can be perceived differently by the consumer as chewy/rubbery, tough, crunchy, and gristly (Gee, 2016; Solo, 2016) .
There are several general theories to the cause of WS and WB (i.e., rapid growth, genetic selection, poor vasculature relative to tissue type, and possible secondary nutrient deficiencies that are brought about by rapid growth), but none has been definitively identified as the causative agent. Utilizing some basic knowledge of muscle biology, physiology, nutrition, and general production, the goal of this study was to evaluate nutritional strategies that may reduce or eliminate WS and WB, all while maintaining growth performance.
MATERIALS AND METHODS

Experimental setup and dietary treatments
To evaluate the multiple dietary strategies that might mitigate the incidence and severity of WB and WS, 6 treatments were conceived and evaluated using a randomized block design. Relative to a standard set of commercial broiler diets that were fed until 45 d of age in a 4-phase growout (treatment 1; starter, grower, finisher, and withdraw), the strategies investigated were as follows: 1) increasing the level of digestible arginine: digestible lysine (dArg: dLys) in the diet from approximately 111% to between 120 and 125% (treatment 2), 2) supplementing vitamin C into the diets at 94.4 mg vitamin C/kg feed (100 ppm on a product basis; treatment 3), 3) increasing the vitamin premix supplementation 2-fold (treatment 4), 4) reducing the dAA density in only the grower phase by 15%, and feeding the exact same starter, finisher, and withdraw diets that were fed to treatment 1 (treatment 5), and 5) combining the 4 strategies just mentioned (treatment 6). A summary of the experimental set-up is provided in the dietary composition tables (Tables 1 to 4) .
Prior to formulating and mixing the feeds (Tables 1  to 4 ), the ingredients (corn, Soybean meal, Dried 1 Vitamin premix added at this rate yields 7,700 IU vitamin A, 5,500 ICU vitamin D3, 55 IU vitamin E, 1.5 mg vitamin K-3, 0.01 mg B12, 6.6 mg riboflavin, 38.5 mg niacin, 9.9 mg d-pantothenic acid, 0.88 mg folic acid, 2.75 mg pyroxidine, 1.54 mg thiamine, 0.08 mg biotin per kg diet.
2 Vitamin premix added at this rate yields 15,400 IU vitamin A, 11,000 ICU vitamin D3, 110 IU vitamin E, 3 mg vitamin K-3, 0.02 mg B12, 13.2 mg riboflavin, 77 mg niacin, 19.8 mg d-pantothenic acid, 1.76 mg folic acid, 5.5 mg pyroxidine, 3.08 mg thiamine, 0.16 mg biotin per kg diet. 3 The digestible amino acid levels of all the diets in the starter phase are equal; however, the level of digestible amino acids in treatments 5 and 6 was reduced by 15% during the grower phase (day 12 to 24). The reduction was made by reducing dLys 15% vs. the control (treatment 1) and maintaining the ratio of all other digestible, essential amino acids to dLys.
4 Rodimet R NP99, Adisseo France SAS. 5 Ajinomoto Heartland Inc., Eddyville, IA 6 Selisseo R ; R, S-2-Hydroxy-4-methylselenobutanoic acid (HMSeBA). Provides 0.30 ppm of organic selenium. Adisseo France SAS.
7 Trace mineral premix added at this rate yields 60.0 mg manganese, 60 mg zinc, 60 mg iron, 7 mg copper, 0.4 mg iodine, a minimum of 6.27 mg calcium, and a maximum of 8.69 mg calcium per kg of diet. The carrier is calcium carbonate and the premix contains less than 1% mineral oil.
8 Active drug ingredient salinomycin sodium, 60 g/lb (60 g/lton inclusion; Huvepharma, Peachtree City, GA 1 Vitamin premix added at this rate yields 7,700 IU vitamin A, 5,500 ICU vitamin D3, 55 IU vitamin E, 1.5 mg vitamin K-3, 0.01 mg B12, 6.6 mg riboflavin, 38.5 mg niacin, 9.9 mg d-pantothenic acid, 0.88 mg folic acid, 2.75 mg pyroxidine, 1.54 mg thiamine, 0.08 mg biotin per kg diet.
8 Active drug ingredient salinomycin sodium, 60 g/lb (60 g/lton inclusion; Huvepharma, Peachtree City, GA). For the prevention of coccidiosis caused by Eimeria tenella, Eimeria necatrix, Eimeria acervulina, Eimeria maxima, Eimeria brunetti, and Eimeria mivati.
9 Quantum blue R 5 G, AB Vista Feed Ingredients, Chesterfield, MO. 10 Rovimix R Stay-C R 35 (L-ascorbic acid monophosphate); provides 330,000 mg L-ascorbic acid/kg product. DSM, Elgin, IL. 11 The level of cellulose (wt: wt) was adjusted based on the amount of L-Arginine, vitamin C, and/or vitamin premix. 12 This source of L-Arginine contains 186% CP; thus, the levels of dietary CP in Treatments 2 and 6 were adjusted based on the amount of supplemental L-Arg and its level of CP. 1 Vitamin premix added at this rate yields 7,700 IU vitamin A, 5,500 ICU vitamin D 3 , 55 IU vitamin E, 1.5 mg vitamin K-3, 0.01 mg B 12 , 6.6 mg riboflavin, 38.5 mg niacin, 9.9 mg d-pantothenic acid, 0.88 mg folic acid, 2.75 mg pyroxidine, 1.54 mg thiamine, 0.08 mg biotin per kg diet.
2 Vitamin premix added at this rate yields 15,400 IU vitamin A, 11,000 ICU vitamin D 3 , 110 IU vitamin E, 3 mg vitamin K-3, 0.02 mg B 12 , 13.2 mg riboflavin, 77 mg niacin, 19.8 mg d-pantothenic acid, 1.76 mg folic acid, 5.5 mg pyroxidine, 3.08 mg thiamine, 0.16 mg biotin per kg diet. 3 The digestible amino acid levels of all the diets in the starter phase are equal; however, the level of digestible amino acids in treatments 5 and 6 was reduced by 15% during the grower phase (day 12 to 24). The reduction was made by reducing dLys 15% vs. the control (treatment 1) and maintaining the ratio of all other digestible, essential amino acids to dLys.
8 Quantum blue R 5 G, AB Vista Feed Ingredients, Chesterfield, MO. 9 Rovimix R Stay-C R 35 (L-ascorbic acid monophosphate); provides 330,000 mg L-ascorbic acid/kg product. DSM, Elgin, IL. 10 The level of cellulose (wt: wt) was adjusted based on the amount of L-Arginine, vitamin C, and/or vitamin premix. 11 This source of L-Arginine contains 186% CP; thus, the levels of dietary CP in treatments 2 and 6 were adjusted based on the amount of supplemental L-Arg and its level of CP.
Distillers' Grains with solubles', meat and bone meal) were all analyzed for apparent metabolizable energy, total and dAAs, proximates (crude protein, fat, fiber, moisture, and ash), and both total and phytate phosphorous using Adisseo's NIR platform, PNE (precise nutrition evaluation). After mixing, the treatment feeds were conditioned and pelleted at 70
• C and fed ad libitum as crumbles in the starter and pellets in the grower, finisher, and withdraw phases.
Animals and management practices
The animal care protocol was developed in accordance with and approved by TX A&M's Institutional Animal Care and Use Committee. On day of hatch, 1980 high-yielding male broiler chicks were randomly allotted to blocked floor pens and dietary treatments based on initial BW. The study consisted of a total of 66 pens (1.83 m × 1.83 m) with each treatment consisting of 11 replicate pens and 30 birds per replicate pen. Pens were located within a tunnel ventilated broiler house, equipped with tube feeders (feeder base circumference of 1.0368 m (area = 0.086 m 2 ), nipple drinkers, and top-dressed recycled litter from 4 previous flocks). Accounting for the feeder space, the stocking density in each pen was 0.109 m 2 /bird, which is greater than typical industry standards in the USA (0.083 m 2 /bird). Environmental heating and lighting programs were consistent with industry standards: day 0 to 3, 24 h of light at 2-foot candles, day 4 to 7, 20 h of light at 2-foot candles, day 8 to 14, 16 h of light at 1-foot candle, day 15 to 42, 16 h of light at 0.2 food candles, and day 43 to 45, 23 h of light at 0.2-foot candles.
The 4-phase growout program consisted of a starter that was fed from day of hatch to 12 d of age, grower from 13 to 24 d of age, finisher from 25 to 36 d, and withdrawal from day 37 to 45; ad libitum access to feed and water was provided throughout the trial. All broilers and feed were weighed on the day the dietary feed changes were made in order to determine an average BW, feed consumption (FC), mortality-corrected FCR, and cumulative FCR.
Processing
Upon completion of the trial (day 45), broilers within each pen were weighed. Seven broilers were selected for processing from each replicate pen (±300 g of the pen mean; 462 birds in total based on 6 treatments; 11 replicates/treatment; 7 birds/replicate). These birds were then placed on an 8-h feed withdrawal period prior to processing on day 46. All birds were conventionally processed in a pilot scale processing facility at Texas A&M University. Birds were stunned (Model SF-7000, Simmons Engineering Corp., Dallas, GA) in a 1% saline bath, 13 mA, 7 s, 500 Hz, DC and bled using a unilateral neck cut. The exsanguinated birds were allowed to bleed for 90 s. All birds were conventionally scalded (61
• C, 45 s), picked in a rotary drum picker (Model sp30ss, Bower Corp., Houghton, LA 52,631) for 25 s, and manually eviscerated. Birds were then chilled to 4
• C within 80 min. The following parameters were measured on the day of processing: fasted live weight, hot carcass weight (WOG HC ), chilled carcass weight (WOG CC ), and the weight of cut-up parts (skinless boneless breast (P. major), tenders (P. minor), wings, and leg quarters (thigh + drumstick)). After weighing, the left and right P. major filets were palpated and scored for WS based on the scoring system of Kuttappan et al. (2012a) and WB based on the scoring system of Tijare et al. (2016) .
Statistical analysis
All data were subjected to an analysis of variance using the General Linear Model Procedure (SPSS V18); pen was used as the experimental unit. Percentage and categorical data (mortality, processing yields, and WS and WB incidence data) were arcsine transformed for analysis. Means that were significantly different at P < 0.05 were separated using Duncan's multiple range test.
RESULTS
Performance
Growth and FCR of the broilers in treatment 1 were in line with performance guidelines for the high-yielding broiler strain that was used. At the end of the starter phase (1 to 12 d of age), no statistical differences in BW (P = 0.232; Table 5 ), FC (P = 0.117; Table 6 ), or mortality-corrected FCR (P = 0.066; Table 7 ) were observed.
In the grower phase (13 to 24 d of age), reducing the amino acid density by 15% in treatments 5 and 6 led to significantly lower BW compared to the first 4 treatments (P < 0.001). Even though there were no differences in FC between treatments in the grower phase (P = 0.379), FCR was statistically greater for treatments 5 and 6 and lowest for treatments 1 through 4 (P < 0.001); this effect was strong enough to affect these treatments across the entire 1 to 24 d-of-age period (P < 0.001).
At the end of the finisher phase (25 to 36 d of age), treatments 2, 3, and 4 had significantly heavier (P < 0.001) BW than treatments 5 and 6. Treatment 4 (2.405 kg/bird; P < 0.001) was significantly heavier than treatment 1 (2.339 kg/bird; P < 0.001). Although no differences were observed in dLys intake between treatments 1 and 5 (P < 0.05; Table 8), the dLys intake for the 1 to 36 d period was lowest for treatments 5 and 6 (P < 0.001). Among the treatments, FC was lowest for treatments 5 and 6 (P = 0.001) and highest for treatment 4 (P = 0.001). Unlike in the starter and grower phases, there was no difference in FCR amongst the 6 treatments (P = 0.183) during the finisher phase. For the 1 to 36 d-of-age period, however, FCR was greatest for treatments 5 and 6, and lowest for treatments 2 through 4 (P < 0.001).
At the end of the withdraw phase (37 to 45 d of age), all dietary treatments had similar BW (P = 0.220) and cumulative FC (day 1 to 45) (P = 0.482 and P = 0.202, respectively). In this phase, there was no difference in dLys intake (P = 0.483); however, there was a significant difference for total dLys consumption over the 1 to 45 d period, whereby treatments 5 and 6 had the lowest Table 5 . Body weight and mortality of male broilers fed diet with a higher ratio of dArg: dLys vitamin premix, vitamin C, and/or a lower digestible amino acid ratio. 4 The digestible amino acid content of the grower diet (day 13 to 24) was reduced by 15% when compared to the control diet (treatment 1); however, the same starter, finisher, and withdraw diets from treatment 1 were fed.
5 Birds were fed, the starter, finisher, and withdraw from treatment 1, and the grower from treatment 5; however, all were supplemented with dietary arginine, vitamin C, and the 2x vitamin premix. Table 6 . Feed consumption of male broilers fed diets with a higher ratio of dArg: dLys, vitamin premix, vitamin C, and/or a lower digestible amino acid ratio. 3 An increase in the vitamin premix concentration (2X). 4 The digestible amino acid content of the grower diet (day 13 to 24) was reduced by 15% when compared to the control diet (treatment 1); however, the same starter, finisher, and withdraw diets from treatment 1 were fed.
5 Birds were fed, the starter, finisher, and withdraw from treatment 1, and the grower from treatment 5; however, all were supplemented with dietary arginine, vitamin C, and the 2x vitamin premix. dLys intake (P < 0.001). Differences in mortalitycorrected FCR were observed for the withdraw phase (P < 0.001) and the complete 1 to 45 d growout (P < 0.001). In the 37 to 45 d period, the mortalitycorrected FCR was greatest for treatments 2, 3, and 4 (P < 0.001) and lowest for treatments 1, 5 and 6 (P = 0.05). For the 1 to 45 d growout, the mortality-corrected FCR was highest for treatments 3 and 4, lowest for treatment 5, and similar between treatments 1, 2, and 6 (P = 0.05). Adjusting the mortality-corrected FCR to a common BW, the FCR was greatest for treatments 3, 4, and 6 and lowest for treatments 1, 2, and 5 (P = 0.006).
No differences were observed in mortality in any of the phases or cumulatively for the entire growout period.
Processing
No differences were observed across the treatments with regard to processing weights of the live, fasted broiler, carcass, or any parts (Table 9 ). Because no differences were observed in live weight or dLys of treatments 1 through 4 at 45 d of age, this was somewhat expected; however, it was not anticipated for treatments 5 and 6 given the lower dLys intake. As a percentage of live, fasted weight, no differences were observed in carcass or parts yield between any of the treatments, with the exception of breast meat yield. On the other hand, all of other dietary treatments were similar to the control diet, including the diet with a reduction in AA density during the grower phase, supplementing vitamin C into the formulation either individually or in Table 7 . Feed conversion of male broilers fed diets with higher ratio of dArg: dLys, vitamin premix, vitamin C, and/or a lower digestible amino acid ratio. a-c Means in columns with different groupings differ significantly at P ≤ 0.05. 1 The dig Arg: dig Lys ratio was increased from 112 to 1.20 in the starter, 114 to 126 in the grower, 115 to 126 in the finisher, and 114 to 126 in the withdraw phase.
2 The level of dietary vitamin C was 94.38 ppm. 3 An increase in the vitamin premix concentration (2X). 4 The digestible amino acid content of the grower diet (day 13 to 24) was reduced by 15% when compared to the control diet (treatment 1); however, the same starter, finisher, and withdraw diets from treatment 1 were fed.
5 Birds were fed, the starter, finisher, and withdraw from treatment 1, and the grower from treatment 5; however, all were supplemented with dietary arginine, vitamin C, and the 2x vitamin premix. the combination treatment reduced breast meat yield (P < 0.001).
White striping and woody breast
Treatments effects were not significant for WS (P = 0.548) at the termination of the trial (Table 10) . Compared to the control-fed birds (treatment 1), the average WB score was significantly reduced (P < 0.001) with the addition of the feed additives in treatments 2 and 3, the reduction in dLys during the grower phase (treatment 5), and their combination (treatment 6; Table 10 ). Reviewing incidence of WB scores for each treatment, it is apparent that there was a significant downward shift (i.e., an improvement) in the incidence of #3 scores (P = 0.033) and an improvement in the #0 scores (P = 0.083). This shift in score is most pronounced when the cumulative incidence of 0&1 (most desired) vs. 2&3 (least desired) scores are compared. Compared to the control diet that had a 2&3 incidence score of 61.3%, the respective incidence of 2&3 scores for treatments 3 and 6 dropped by 41.48 and 36.87%. Comparing the 0&1 incidence of the controlfed birds (38.70%), the incidence of 0&1 scores amongst treatments 2, 3, 4, 5, and 6 increased by 31. 09, 65.68, 3.36, 27 .08, and 58.40%, respectively. Just as for the mean scores, treatment 1 had the highest and treatment 3 had the lowest incidence of 2&3 scores (P = 0.048); the converse was observed for the 0&1 scores (P = 0.048). Although the inclusion of vitamin C (treatment 3) reduced the average WB score by 32% and improved the incidence of 0&1 scores by 65.68%, a Table 9 . Processing weights and processing yields of male broilers fed diets with a higher ratio of dArg: dLys, vitamin premix, vitamin C, and/or a lower digestible amino acid ratio. 2 The level of dietary vitamin C was 94.38 ppm. 3 An increase in the vitamin premix concentration (2X). 4 The digestible amino acid content of the grower diet (day 13 to 24) was reduced by 15% when compared to the positive control diet (treatment 1); however, the same starter, finisher, and withdraw diets from treatment 1 were fed.
5 Birds were fed, the starter, finisher, and withdraw from treatment 1, and the grower from treatment 5; however, all were supplemented with dietary arginine, vitamin C, and the 2x vitamin premix. Table 10 . Meat quality measurements and woody breast profile of male broilers that are fed diets with a higher ratio of dArg: dLys, vitamin premix, vitamin C, and/or a lower digestible amino acid ratio. 4 The digestible amino acid content of the grower diet (day 13 to 24) was reduced by 15% when compared to the positive control diet (treatment 1); however, the same Starter, finisher, and withdraw diets from treatment 1 were fed.
5 Birds were fed, the starter, finisher, and withdraw from treatment 1, and the grower from treatment 5; however, all were supplemented with dietary arginine, vitamin C, and the 2x vitamin premix. significant reduction in breast meat yield was unexpectedly observed.
DISCUSSION
Woody breast and white striping are described very well by Petracci and Cavani (2012) , Kuttappan et al. (2013), and Shivo et al. (2014) . Across these studies, the 2 myopathies or conditions are characteristically expressed by modern, fast-growing, and high-yielding broiler strains that are grown over a long period of time, to a heavy weight classes (e.g., 56 to 63 d at 3.63 to 4.76 kg/bird). Although the incidence and severity of WS and WB are certainly age related, previous research conducted by Texas A&M University was able to elicit a >95% incidence in WB for high-yielding male broilers at 49 d of age when nutrient-dense diets were fed; broilers had an average BW of 3.77 kg/bird (ADG = 89.8 g/d) and a FCR of 1.60 (unpublished data). Regardless of the incidence and severity, the previously mentioned authors observed that breast tissue with WB foci exhibit polyphasic myodegeneration and regeneration, variable amounts and types of muscle and connective tissue, perivenular lymphocytic accumulation, and variable levels of vasculature thickening and damage. In addition, to the physical changes within the tissue, there is often a characteristic accumulation of a serous extracellular exudate that lies between the skin and the breast tissue.
Defining the etiology of WS and WB, several authors have studied whether WS and WB are heritable (i.e., genetics), nutritional, environmental, or metabolic in nature. The fact today is that no one study has unequivocally determined what causes the 2 myopathies. Although the WS and WB are not a food safety issue, the visible and textural differences of each are different enough from "normal" that 1) customers (i.e., grocery and restaurant chains) and consumers (i.e., anyone that physically purchases and eats the prepared product or cut of meat) have started to recognize WS and WB, 2) recognition of the difference between effected vs. noneffected meat, and 3) demanding changes in how broilers are raised for meat.
This study sought to define nutritional strategies that might lead to the elimination or a significant reduction in one or both conditions. This was accomplished by using feed additives or levels of nutrients that are known to have nutritional and physiological properties. The issues today are helping to define the etiology and solutions for the 2 muscle myopathies. In order to understand these myopathies, the cellular and muscular structure must be understood. Skeletal muscle cell types are divided into 2 categories: 1) glycolytic (white fiber, rapid twitch) and 2) aerobic/oxidative (red fiber, slow twitch). Regardless of cell type, the hierarchical structure of muscle tissue is based on satellite cells that develop in ovo and early on post-hatch (Ordahl et al., 1999; Sobolewska et al., 2011; Harthan et al., 2013) .
Satellite cells are essential to muscle development and repair due to the ability to be the "stem cells" that give rise to mono-nucleated myoblasts through proliferation, differentiation, and fusion with adjacent muscle fibers (Moss and Leblond, 1971) . The degree to which these processes take place depends on the concentration and location of satellite cells, and the fiber type. Whereas white, fast-twitching, glycolytic muscle fibers contain few satellite cells, the slow-twitch, oxidative muscle fibers contain many. In the P. major of broiler chickens (fast twitch, glycolytic), satellite cells are found in the greatest concentration at the peripheral edge of the growing breast tissue, whereas they are more numerous and diffuse throughout the slow-twitch, oxidative muscle fibers (e.g., Sartorius major). In both muscle fiber types, regeneration is an ongoing process that occurs when new fibers are produced during postnatal growth and further regenerated after injury or death of muscle (Gerrard and Grant, 2003; Mann et al., 2011; Harthan et al., 2013) . Compounding the cellular hierarchy and rapid, continuous and simultaneous rates of protein turnover (i.e., accretion vs. degradation) that occurs within the muscle cells (Goll et al., 1992; Gerrad and Grant, 2003) , the breast tissue (P. major and P. minor) is tightly compartmentalized against the keel and is poorly vascularized when compared to red muscle types (e.g., S. major) (Bilgili, 2013) . Due to the difference in number and location of the satellite cell populations, the amount of vasculature within each of the muscle types, and the continuous remodeling of the breast tissue on a macro scale, the response time and degree of tissue repair often occur at disparate rates.
In this study, multiple nutritional strategies were investigated in an effort to mitigate the presence and severity of WS and WB, without impacting performance. As 1 of 5 nutritional strategies, L-arginine was selected as a potential mitigating strategy, as BautistaOrtega and Ruiz-Feria (2010) demonstrated that feeding higher levels of arginine caused vasodilation via an increase in nitric oxide production. As a result of this dilation, it is theorized that efficiency of nutrient and metabolite exchange in the poorly vascularized breast tissue can be improved (Jobgen et al., 2006) . The enhanced nutrient usage is also crucial in the hypertrophy of the muscle tissue (Fernandes et al., 2009) .
Pulmonary hypertension syndrome, a metabolic disorder that commonly affects fast growing broilers and is often found in hypoxic conditions, was observed to be impacted by the inclusion of arginine, vitamin C, and vitamin E (Bautista-Ortega and Ruiz-Feria, 2010). The results from the study indicated that the high arginine dietary treatment and Arg + Vit E + Vit C treatment both showed a significant reduction in pulmonary artery reactivity. Sumou et al. (2006) also reported arginine's ability to reduce hypoxic pulmonary artery remodeling in broilers. These data suggest that arginine improved the flow of oxygen in the blood, which in turn had a positive effect on the hypoxic state of the muscle. Bilgili (2013) hypothesized that localized hypoxia is present in WB tissue due to the reduction in the capillary supply. Mutryn et al. (2015) validated the hypothesis when the gene, hypoxia-inducible factor −1, was discovered to activate the transcription factor that is present in birds affected with WB. One of the genes regulated by hypoxia-inducible factor −1, PLOD2, is upregulated in WB-affected birds. This important gene, associated with extracellular stiffening and collagen alignment, can be linked to fibrosis, which is a common characterization of WB (Van der Slot et al., 2003) . This upregulation process may also play a role in the changes that occur within in the extracellular matrix which causes stiffness of WB. From these studies, it can be suggested that when hypoxia is present in the muscle and there is an inclusion of arginine, there is an overall reduction of hypoxia, reducing WB severity. The present hypothesis confirmed the previous studies mentioned by showing the reduction of WB by the use of dietary arginine treatments while also establishing a lack of impact on the overall breast meat yield.
Additionally, supplementing vitamin C has been recommended to reduce the incidence of WB in today's modern broilers . Vitamin C has also been reported to provide support for anti-oxidative metabolism by eliminating oxygen-derived free radicals (Xiang et al., 2002) and for the biosynthesis of collagen . Recently, Abasht et al. (2016) hypothesized that the glycogen depletion that is seen in WB-affected birds can be contributed to the overactivation of the ascorbate (vitamin C) biosynthesis pathway. Abasht et al. (2016) concluded with the recommendation of a vitamin C supplementation to decrease the activity of the pathway and reduce the damage done to the breast tissue.
In a study conducted by Mutryn et al. (2015) , WBaffected birds were observed to have undergone oxidative stress, caused by an increase in reactive oxygen species (ROS). An increase in ROS is detrimental to muscles due to its ability to change cellular pathways that ultimately results in a change in skeletal muscle remodeling and adaptation (Powers et al., 2010) . It was hypothesized that vitamin E and vitamin C may neutralize ROS by reacting with nitric oxide to produce peroxynitirte, in turn sparing nitric oxide and increasing vasodilation (Bautista-Ortega and Ruiz-Feria, 2010) . Similarly, vitamin C has also been reported to improve resistance to many metabolic stressors such as hypoxia, which contributes to the production of oxygenderived free radicals (Agudelo, 1983; Al-Taweil and Kassab, 1990; Bottje and Wideman, 1995) . The elimination of oxygen-derived free radicals with the use of vitamin C is a possible explanation for the reduction of hypoxia (Xiang et al., 2002) . The current study showed the inclusion of vitamin C reduced the WB score significantly when compared to the control diet perhaps through the elimination of hypoxia.
Furthermore, in the current study, the reduction in amino acidy density in the grower phase was believed to maximize satellite cell development to allow the breast tissue to recover from rapid growth in the starter phase (Powell et al., 2014) . Amino acids are known to regulate key metabolic pathways, optimize muscle growth, and enhance protein synthesis (Wu, 2009) . Previous studies reported the necessity of satellite cell development in the neonatal stage for protein synthesis and muscle development (Powell et al., 2013) . Satellite cells were observed by Pophal et al. (2004) to be sensitive to nutrition in their mitotic activity when fed differing levels of lysine. Similarly, Powell et al. (2013) observed the reduction in satellite cell activity when Met/Cys were reduced in the diet. Decreasing amino acid density in the current study reduced BW and increased FCR throughout the grower phase; however, compensatory gain resulted in similar growth performance parameters to the control at the conclusion of the experiment. These results are congruent with the study conducted by Kidd et al. (2005) , which found broilers fed lower amino acid diets experience a reduction in BW, feed conversion, and carcass yield. These studies suggest the lowered AA density reduced BW in the grower phase by decreasing satellite cell activity that allowed for the recovery of the muscle. In conclusion, the current study reduced amino acid density during the grower phase and did not impact final growth performance but did reduce the overall incidence of WB without negatively impacted breast yield similar to the arginine dietary treatment.
These data indicate that the nutritional strategies including an increase in digestible arginine, inclusion of vitamin C. or a reduced AA density diet during the grower phase could be possible solutions to mitigate WB. Arginine improved vasculature in hypoxic conditions that has been found in WB-affected broilers. Similarly, vitamin C had a positive impact on oxidative stress by eliminating oxygen-derived free radicals. Furthermore, reduced AA density reduced satellite cell development in the grower phase for the recovery of breast tissue. Subsequent studies need to be conducted on differing inclusion rates of arginine and vitamin C to determine the maximum beneficial level. Additionally, subsequent studies should evaluate multiple time period of AA density reduction to determine the most appropriate time to utilize this strategy.
